Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-05-04 6:47 pm |
N/A N/A |
First Wave BioPharma Inc. | FWBI | Hoffman David Andrew Director |
0 | $0 | 181,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-02 6:02 pm |
N/A 2032-03-01 |
First Wave BioPharma Inc. | FWBI | Romano Sarah Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:07 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | CASAMENTO CHARLES J Director |
34,482 | $0 | 34,482 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:07 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | Riddell Alastair Director |
34,482 | $0 | 34,482 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:07 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | Coelho Mary Theresa Director |
34,482 | $0 | 34,482 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:07 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | BORKOWSKI EDWARD Director |
34,482 | $0 | 34,482 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:07 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:07 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | Pennington James CHIEF MEDICAL OFFICER |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:07 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | Oakes Gregory Director |
34,482 | $0 | 34,482 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:07 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | Schneiderman Daniel H CHIEF FINANCIAL OFFICER |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-03 9:06 pm |
N/A 2032-01-03 |
First Wave BioPharma Inc. | FWBI | Schramm Vern Lee Director |
34,482 | $0 | 34,482 (Direct) |
View |
| 2021-09-09 Option Award |
2021-09-13 8:08 pm |
N/A 2031-09-09 |
AzurRx BioPharma Inc. | AZRX | Coelho Mary Theresa Director |
10,310 | $0 | 10,310 (Direct) |
View |
| 2021-07-09 Option Award |
2021-07-09 5:11 pm |
N/A 2031-07-09 |
AzurRx BioPharma Inc. | AZRX | Pennington James CHIEF MEDICAL OFFICER |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-06-30 Other |
2021-07-02 5:09 pm |
N/A 2030-07-15 |
AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER |
285,006 | $0 | 285,006 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 5:09 pm |
N/A 2031-06-30 |
AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER |
285,006 | $0 | 285,006 (Direct) |
View |
| 2021-06-30 Other |
2021-07-02 5:07 pm |
N/A 2030-07-15 |
AzurRx BioPharma Inc. | AZRX | SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD |
900,000 | $0 | 1,200,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 5:07 pm |
N/A 2031-06-30 |
AzurRx BioPharma Inc. | AZRX | SAPIRSTEIN JAMES PRES, CEO & CHAIRMAN OF BOARD |
900,000 | $0 | 1,200,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 9:48 pm |
N/A 2031-01-03 |
AzurRx BioPharma Inc. | AZRX | Oakes Gregory Director |
41,237 | $0 | 41,237 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 9:46 pm |
N/A 2031-01-03 |
AzurRx BioPharma Inc. | AZRX | Schramm Vern Lee Director |
41,237 | $0 | 41,237 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 9:43 pm |
N/A 2031-01-03 |
AzurRx BioPharma Inc. | AZRX | Riddell Alastair Director |
41,237 | $0 | 41,237 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 9:40 pm |
N/A 2031-01-03 |
AzurRx BioPharma Inc. | AZRX | CASAMENTO CHARLES J Director |
41,237 | $0 | 41,237 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 9:39 pm |
N/A 2031-01-03 |
AzurRx BioPharma Inc. | AZRX | BORKOWSKI EDWARD Director |
41,237 | $0 | 41,237 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:54 pm |
N/A 2030-07-15 |
AzurRx BioPharma Inc. | AZRX | Pennington James CHIEF MEDICAL OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:52 pm |
N/A N/A |
AzurRx BioPharma Inc. | AZRX | BORKOWSKI EDWARD Director |
256,422 | $0 | 256,422 (Direct) |
View |
| 2020-07-16 Other |
2020-07-20 9:51 pm |
N/A 2030-01-02 |
AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER |
35,006 | $0 | 585,006 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:51 pm |
N/A 2030-07-15 |
AzurRx BioPharma Inc. | AZRX | Schneiderman Daniel H CHIEF FINANCIAL OFFICER |
285,006 | $0 | 585,006 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:50 pm |
N/A 2030-07-15 |
AzurRx BioPharma Inc. | AZRX | SAPIRSTEIN JAMES PRESIDENT AND CEO |
1,264,948 | $0 | 1,264,948 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-01 5:10 pm |
2019-12-20 2020-09-20 |
AzurRx BioPharma Inc. | AZRX | BORKOWSKI EDWARD Director |
100,000 | $100,000 | 100,000 (Direct) |
View |